[fcb5af]: / literature / by_gene_clean / HLA-B.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 35759244 10.1002/iid3.666 2022 EBV protection- and susceptibility-related HLA alleles and EBV status in the Chinese population: A single-center study. HLA-B
2 35953408 10.1016/j.humimm.2022.08.002 2022 HLA homozygosity is associated with Non-Hodgkin lymphoma. HLA-B
3 33512416 10.1182/blood.2020007245 2021 Frequent genetic alterations in immune checkpoint-related genes in intravascular large B-cell lymphoma. HLA-B
4 33747936 10.3389/fonc.2021.622648 2021 Genomic Mutation Profile of Primary Gastrointestinal Diffuse Large B-Cell Lymphoma. HLA-B
5 33964277 10.1016/j.humpath.2021.04.014 2021 Relative frequency and clinicopathologic characteristics of MYC-rearranged follicular lymphoma. HLA-B
6 34330762 10.1136/jitc-2021-002410 2021 High-affinity T-cell receptor specific for MyD88 L265P mutation for adoptive T-cell therapy of B-cell malignancies. HLA-B
7 34717720 10.1186/s13045-021-01201-3 2021 HLA alleles associated with asparaginase hypersensitivity in Chinese children. HLA-B
8 34830986 10.3390/cancers13225833 2021 HLA Expression in Relation to HLA Type in Classic Hodgkin Lymphoma Patients. HLA-B
9 34926267 10.3389/fonc.2021.765544 2021 <i>SEPT6</i>_<i>TRIM33</i> Gene Fusion and Mutated TP53 Pathway Associate With Unfavorable Prognosis in Patients With B-Cell Lymphomas. HLA-B
10 31958417 10.1016/S2352-3026(19)30220-0 2020 Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial. HLA-B
11 32072624 10.1111/bjh.16398 2020 Variation in the Human Leukocyte Antigen system and risk for endemic Burkitt lymphoma in northern Uganda. HLA-B
12 32883310 10.1186/s12977-020-00536-y 2020 HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina. HLA-B
13 30396848 10.1016/j.jcyt.2018.08.001 2019 Epstein-Barr Virus (EBV)-derived BARF1 encodes CD4- and CD8-restricted epitopes as targets for T-cell immunotherapy. HLA-B
14 30715139 10.1093/asj/sjz021 2019 Differences in Human Leukocyte Antigen Expression Between Breast Implant-Associated Anaplastic Large Cell Lymphoma Patients and the General Population. HLA-B
15 30871628 10.1186/s40425-019-0538-8 2019 Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab. HLA-B
16 31026237 10.1097/QAI.0000000000002027 2019 Increasing Levels of Serum Heat Shock Protein 70 Precede the Development of AIDS-Defining Non-Hodgkin Lymphoma Among Carriers of HLA-B8-DR3. HLA-B
17 31101215 10.1016/j.transproceed.2019.04.014 2019 Non-Hodgkin Lymphoma in a Kidney Transplant Patient: A Case Report. HLA-B
18 31215275 10.1080/10428194.2019.1617858 2019 The association between HLA and non-Hodgkin lymphoma subtypes, among a transplant-indicated population. HLA-B
19 31325731 10.1016/j.leukres.2019.106193 2019 Chronic lymphocytic leukemia patients with HLA-B27 referred for allogeneic hematopoietic stem cell transplantation do not have worse outcomes: Results of a population-based case series analysis in British Columbia, Canada. HLA-B
20 29735552 10.1158/0008-5472.CAN-17-2900 2018 HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes. HLA-B
21 30032036 10.1016/j.neo.2018.07.001 2018 Mutational Intratumor Heterogeneity is a Complex and Early Event in the Development of Adult T-cell Leukemia/Lymphoma. HLA-B
22 27696192 10.1007/s12185-016-2101-4 2017 Fulminant type I diabetes mellitus associated with nivolumab in a patient with relapsed classical Hodgkin lymphoma. HLA-B
23 28053195 10.1182/blood-2016-09-737536 2017 TCR-based therapy for multiple myeloma and other B-cell malignancies targeting intracellular transcription factor BOB1. HLA-B
24 28405493 10.1080/2162402X.2016.1219825 2017 HLA class I-restricted <i>MYD88</i> L265P-derived peptides as specific targets for lymphoma immunotherapy. HLA-B
25 28659916 10.3389/fimmu.2017.00675 2017 HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy. HLA-B
26 28811957 10.1080/2162402X.2017.1321184 2017 Mapping the human T cell repertoire to recurrent driver mutations in MYD88 and EZH2 in lymphoma. HLA-B
27 29147614 10.1080/2162402X.2017.1356964 2017 Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy. HLA-B
28 25753140 10.1111/jdv.13083 2016 Mycosis fungoides: association of KIR ligands and HLA-DQB1*05 with bad prognosis of the disease. HLA-B
29 26841353 10.1002/art.39515 2016 Activation-Induced Killer Cell Immunoglobulin-like Receptor 3DL2 Binding to HLA-B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis. HLA-B
30 27063556 10.1016/j.gene.2016.04.017 2016 The associations of HLA-A, -B, DRB1 alleles and haplotypes in Turkish lymphoma patients. HLA-B
31 27776339 10.18632/oncotarget.12778 2016 Generation of CD20-specific TCRs for TCR gene therapy of CD20low B-cell malignancies insusceptible to CD20-targeting antibodies. HLA-B
32 25569183 10.1038/ncomms6751 2015 A genome-wide association study of marginal zone lymphoma shows association to the HLA region. HLA-B
33 25611436 10.1111/ejh.12513 2015 Genetic susceptibility to diffuse large B-cell lymphoma in a pooled study of three Eastern Asian populations. HLA-B
34 25648508 10.1002/ijc.29467 2015 Modeling HLA associations with EBV-positive and -negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesis. HLA-B
35 25672859 10.5692/clinicalneurol.55.13 2015 [Neuro-neutrophilic disease suspected by human leukocyte antigen (HLA) typing and brain biopsy: a case report]. HLA-B
36 26040094 NA 2015 A coincidence of HLA-B27 negative spondyloarthritis and paravertebral non-Hodgkin's lymphoma--a lesson to be learnt from the past experience. HLA-B
37 26189878 10.1111/tan.12604 2015 Human leukocyte antigens and genetic susceptibility to lymphoma. HLA-B
38 26334430 10.1097/MPH.0000000000000419 2015 HLA Polymorphism in Algerian Children With Lymphomas. HLA-B
39 24533560 10.1111/jdv.12391 2014 Immunogenetic factors in mycosis fungoides: can the HLA system influence the susceptibility and prognosis of the disease? Long-term follow-up study of 46 patients. HLA-B
40 24755352 10.1016/j.humimm.2014.04.004 2014 Killer cell immunoglobulin-like receptors in Thai patients with leukemia and diffuse large B-cell lymphoma. HLA-B
41 24963477 10.1155/2014/231236 2014 The association of HLA-class I and class II with Hodgkin's lymphoma in Iranian patients. HLA-B
42 25261932 10.1038/ng.3105 2014 Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma. HLA-B
43 25549594 IJIv11i4A5 2014 HLA-A*26 and susceptility of iranian patients with non-Hodgkin lymphoma. HLA-B
44 23326239 10.1371/journal.pgen.1003147 2013 A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1). HLA-B
45 23843497 10.1182/blood-2013-02-483420 2013 HLA specificities are related to development and prognosis of diffuse large B-cell lymphoma. HLA-B
46 22340965 10.1016/S1470-2045(12)70004-9 2012 Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study. HLA-B
47 22489945 10.1111/j.1399-0039.2012.01868.x 2012 Somatic mutations in the HLA genes of patients with hematological malignancy. HLA-B
48 22781790 NA 2012 [The impact of HLA high resolution typing mismatching of donor-recipient pairs on outcome of unrelated donor hematopoietic stem cell transplantation]. HLA-B
49 23092091 NA 2012 [Incidence of uveitis in the northern Kyushu region of Japan --comparison between the periods of 1996-2001 and 2003-2008]. HLA-B
50 21982422 10.1016/S1470-2045(11)70260-1 2011 Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis. HLA-B
51 22125456 10.1100/2011/373876 2011 Human leukocyte antigen class I and II alleles and overall survival in diffuse large B-cell lymphoma and follicular lymphoma. HLA-B
52 20110857 10.1097/TP.0b013e3181c69855 2010 Impact of HLA mismatching on incidence of posttransplant non-hodgkin lymphoma after kidney transplantation. HLA-B
53 20385791 10.1182/blood-2010-01-266775 2010 Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology. HLA-B
54 20522710 10.1182/blood-2010-02-270199 2010 Comparative analysis of predicted HLA binding of immunoglobulin idiotype sequences indicates T cell-mediated immunosurveillance in follicular lymphoma. HLA-B
55 21041953 10.1172/JCI42869 2010 BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy. HLA-B
56 19032105 10.1086/594373 2009 The effects of acute malaria on Epstein-Barr virus (EBV) load and EBV-specific T cell immunity in Gambian children. HLA-B
57 19265139 10.4049/jimmunol.0802316 2009 Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells. HLA-B
58 19654554 10.1097/QAI.0b013e3181b017d5 2009 The major histocompatibility complex conserved extended haplotype 8.1 in AIDS-related non-Hodgkin lymphoma. HLA-B
59 17971052 10.1111/j.1399-0039.2007.00954.x 2008 Haplotype-specific pattern of association of human major histocompatibility complex with non-Hodgkin's lymphoma outcome. HLA-B
60 18301962 10.1007/s12185-008-0040-4 2008 Association of HLA alleles with non-Hodgkin's lymphoma in Korean population. HLA-B
61 18587537 10.1007/s11060-008-9630-5 2008 Primary CNS lymphoma and HLA class I and II alleles in a German cohort of immunocompetent patients. HLA-B
62 18724291 10.1038/bmt.2008.145 2008 Current status of hematopoietic stem cell transplantations in Vietnam. HLA-B
63 17311253 10.1002/gcc.20436 2007 Association of human leukocyte antigen ancestral haplotype 8.1 with adverse outcome of non-Hodgkin's lymphoma. HLA-B
64 17437273 10.1002/ijc.22767 2007 Risk of human T-lymphotropic virus type I-associated diseases in Jamaica with common HLA types. HLA-B
65 17909631 10.1172/JCI32377 2007 HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection. HLA-B
66 16257267 10.1016/j.clim.2005.09.006 2006 HLA B44 is associated with decreased severity of autoimmune lymphoproliferative syndrome in patients with CD95 defects (ALPS type Ia). HLA-B
67 17145860 10.1158/0008-5472.CAN-06-2326 2006 Isolation of germ cells from leukemia and lymphoma cells in a human in vitro model: potential clinical application for restoring human fertility after anticancer therapy. HLA-B
68 17194665 NA 2006 Paraneoplastic stiff-person syndrome, heterotopic soft tissue ossification and gonarthritis in a HLA B27-positive woman preceding the diagnosis of Hodgkin's lymphoma. HLA-B
69 15916683 10.1111/j.1365-2141.2005.05499.x 2005 Epstein-Barr virus-associated familial Hodgkin lymphoma: paediatric onset in three of five siblings. HLA-B
70 14634793 10.1007/s00277-003-0809-8 2004 Decreased frequency of HLA-B35 in patients with gastric MALT lymphoma. HLA-B
71 15786697 NA 2004 Impact of standardization on clinical cell analysis by flow cytometry. HLA-B
72 13130260 NA 2003 [Characteristics of uveitis presenting de novo in the elderly]. HLA-B
73 14515258 10.1002/eji.200324182 2003 Differential effects of US2, US6 and US11 human cytomegalovirus proteins on HLA class Ia and HLA-E expression: impact on target susceptibility to NK cell subsets. HLA-B
74 11917131 10.1073/pnas.072495599 2002 MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells. HLA-B
75 12352909 10.1097/00007890-200208270-00012 2002 Identification of Epstein-Barr virus-specific CD8+ T lymphocytes in the circulation of pediatric transplant recipients. HLA-B
76 11169449 10.1002/1521-4141(200101)31:1&lt;156::aid-immu156&gt;3.0.co;2-p 2001 Mimotopes for tumor-specific T lymphocytes in human cancer determined with combinatorial peptide libraries. HLA-B
77 10715516 10.1016/s0198-8859(99)00186-x 2000 Differential expression of human major histocompatibility class I loci: HLA-A, -B, and -C. HLA-B
78 11035374 10.1038/sj.bmt.1702565 2000 First manifestations of seronegative spondylarthropathy following autologous stem cell transplantation in HLA-B27-positive patients. HLA-B
79 11122133 NA 2000 Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation. HLA-B
80 10566592 10.1016/s0198-8859(99)00076-2 1999 Acquisition of a stimulatory activity for Vgamma9/Vdelta2 T cells by a Burkitt's lymphoma cell line without loss of HLA class I expression. HLA-B
81 10622558 10.1016/s0168-8278(99)80372-9 1999 Autoimmunity and extrahepatic manifestations in hepatitis C virus infection. HLA-B
82 9577643 NA 1998 [Post-transplant EBV-associated lymphoproliferative disorders--report of two cases]. HLA-B
83 9753343 10.1097/00007890-199809150-00013 1998 Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including anti-T-cell antibodies. HLA-B
84 9780337 10.1056/NEJM199810223391701 1998 Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program. HLA-B
85 9120290 NA 1997 Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy. HLA-B
86 7761977 10.1111/j.1399-0039.1995.tb02437.x 1995 The HLA-A,B,C genotype of the class I negative cell line Daudi reveals novel HLA-A and -B alleles. HLA-B
87 7909466 10.3109/10428199409059592 1994 Human major histocompatibility complex contains several leukemia susceptibility genes. HLA-B
88 8107207 10.1128/JVI.68.3.1442-1448.1994 1994 Down-regulation of HLA antigens by the adenovirus type 2 E3/19K protein in a T-lymphoma cell line. HLA-B
89 8302299 10.1016/0161-5890(94)90138-4 1994 Generation of HLA-B55 restricted T lymphocyte mediated cytotoxicity against autologous LCL. HLA-B
90 1285893 10.1111/j.1600-0897.1992.tb00806.x 1992 Diffuse infiltrative lymphocytosis syndrome in children and adults infected with HIV-1: a model of rheumatic illness caused by acquired viral infection. HLA-B
91 1738086 NA 1992 HLA-B35 is associated with accelerated progression to AIDS. HLA-B
92 1655115 NA 1991 Cell phenotype dependent expression of MHC class I antigens in Burkitt's lymphoma cell lines. HLA-B
93 1899854 10.1002/ijc.2910470412 1991 Aberrant expression of HLA class-I antigens in Burkitt lymphoma cells. HLA-B
94 2066181 10.1002/ijc.2910470703 1991 Differential transcription inducibility by interferon of the HLA-A3 and HLA-B7 class-I genes. HLA-B
95 2290171 NA 1990 Lymphoma presenting as a popliteal mass in a patient with rheumatoid arthritis. HLA-B
96 2535859 NA 1989 IFN-mediated differential regulation of the expression of HLA-B7 and HLA-A3 class I genes. HLA-B
97 2561749 NA 1989 [Cluster headache, Epstein-Barr and Burkitt's lymphoma virus infections]. HLA-B
98 2804917 10.1002/1097-0142(19891201)64:11&lt;2259::aid-cncr2820641113&gt;3.0.co;2-0 1989 Possible disorder of B-cell-related surveillance and malignant lymphoma of the thyroid. HLA-B
99 2450918 NA 1988 Specific associations of fluorescent beta-2-microglobulin with cell surfaces. The affinity of different H-2 and HLA antigens for beta-2-microglobulin. HLA-B
100 2894907 NA 1988 HLA and adult T cell leukaemia: HLA-linked genes controlling susceptibility to human T cell leukaemia virus type I. HLA-B